![]() |
市場調查報告書
商品編碼
1383499
2030 年醫療機器人市場預測:按類型、產品、配置、配銷通路、應用、最終用戶和地區進行的全球分析Medical Robotics Market Forecasts to 2030 - Global Analysis By Type, Product, Setting, Distribution channel, Application, End User and By Geography |
根據Stratistics MRC的數據,2023年全球醫療機器人市場規模為136.4億美元,預計2030年將達到424.3億美元,預測期內年複合成長率為17.6%。
醫療機器人是醫院和其他醫療機構使用的專業服務機器人,旨在提高為患者提供的護理品質。有助於外科醫師進行更準確、更有效的手術。它還最大限度地減少了醫務人員的工作量,讓他們有更多的時間照顧病人。
根據國家安全委員會 (NSC) 的數據,年度約有 160 萬至 380 萬名運動員遭受某種類型的身體傷害。
手術機器人已成為現代外科新的成長點和技術培養箱。機器人輔助手術的創建是為了克服當前微創手術技術的限制或提高外科醫生在對患者開放性手術時的表現。微創手術中使用的手術機器人可以幫助減少疤痕、加速癒合並縮短恢復時間。由於對微創手術治療的需求不斷增加以及醫療機器人輔助手術過程的應用,手術現在變得更加有效。因此,這些因素正在推動市場成長。
在醫療機器人市場中,高昂的初始成本是一個重要的抑制因素,阻礙了市場的成長。機器人硬體,例如手術機器人和機器人輔助手術系統,初期成本可能難以承受。此外,醫療機器人的整合通常需要專用的手術室和基礎設施的改變,這進一步增加了初始成本。然而,醫務人員必須接受專門培訓才能安全操作醫療機器人並執行手術。
透過利用機器人系統,藥物輸送變得更加精確、有針對性和高效。醫療機器人可以精確調整給藥時間和給藥量,確保適量到達所需區域。這對於需要極高精確度的醫療程序特別有用,例如靜脈注射藥物或癌症治療。此外,機器人技術可以促進標靶藥物輸送,將藥物特異性引導至受影響的組織和細胞,最大限度地減少與健康組織和細胞的接觸。這種方法可以提高治療效果,同時最大限度地減少副作用。這些因素正在推動市場需求。
醫療機器人需要定期維修、定期保養。為了避免代價高昂的中斷,可靠的更換零件供應和熟練的維修技術人員至關重要。醫療機器人在診斷和手術等各種醫療保健場合中不可或缺。意外故障或故障可能會導致嚴重停機、延誤患者治療並給醫護人員帶來不便。醫療機器人的故障可能會導致錯誤、問題和不利結果,使病患安全面臨風險。因此,維護和維修是市場需求的主要障礙。
COVID-19大流行對醫療機器人市場產生了重大影響。由於需要盡量減少人與人之間的接觸,對醫療機器人的需求激增。隨著用於遠端醫療會診和遠端醫療的機器人的發展,遠距醫療和遠距醫療正在迅速普及,在保持社交距離的同時促進患者護理。也推出了使用 UV-C 光對醫療環境進行消毒並降低感染風險的機器人。在此期間,研究和開發加速,產生了用於樣本採集、診斷和遠端監控的機器人等創新。這次疫情也凸顯了醫療機器人在透過模擬程序培訓醫護人員方面的作用。
腹腔鏡部分估計佔最大佔有率。腹腔鏡設備已被證明是用於診斷和治療目的的有效工具。人們注意到,包括腹腔鏡手術在內的手術的資金和報銷政策有所增加。近年來,機器人輔助腹腔鏡手術越來越受歡迎。此外,由於腹腔鏡手術具有切口小或無切口、住院時間短、疼痛減輕、恢復快、疤痕少、失血少等優點,機器人輔助微創手術的需求正在增加。
由於醫院和診所允許患者在一次就診中獲得所有類型的治療選擇和諮詢,因此醫院部門預計在預測期內將出現良好的成長。年度的醫院和手術數量正在推動醫院和診所的成長。醫療機器人擴大用於手術、靜脈注射準備、消毒、物流和診斷等各種任務,為醫院和診所市場做出了貢獻。
由於其先進的醫療基礎設施、強大的研發能力和大量的醫療機構,北美在預測期內佔據了最大的市場佔有率。該地區是技術創新的中心,許多知名醫療機器人製造商、學術機構和醫療機構不斷挑戰產業極限。北美在遠端醫療、機器人輔助手術、復健機器人等技術創新方面處於世界領先地位,帶動了該地區的市場需求。
由於已開發國家老年人口的增加和醫療保健的全球化,預計歐洲在預測期內將出現盈利成長。歐洲擁有眾多醫療機器人研究設施和創新中心。為了加速醫療機器人技術的開發和實施,這些中心與學術機構和產業領導者合作。歐洲國家繼續表現出對醫療保健投資的堅定承諾,為該地區的醫療機構提供財務支持。
According to Stratistics MRC, the Global Medical Robotics Market is accounted for $13.64 billion in 2023 and is expected to reach $42.43 billion by 2030 growing at a CAGR of 17.6% during the forecast period. Medical robots are professional service robots used in hospitals and other healthcare facilities to improve the quality of care given to patients. It facilitates more precise and effective operations by surgeons. They create a substantial operational procedure that offers efficacy and low-cost investments in healthcare amenities while also minimizing the workload of medical staff, releasing them to spend more time directly caring for patients.
According to the National Safety Council (NSC), it was stated that about 1.6 to 3.8 million athletes get some sort of physical injury annually.
Surgical robotics has emerged as a new growth point and technological incubator in modern surgery. Robot-assisted surgeries were created to overcome the limitations of current minimally invasive surgery technologies or to enhance the abilities of surgeons during open surgery on a patient. Surgical robotics used in minimally invasive surgery helps to minimize scarring, speed up healing, and shorten recovery times. Surgical operations are now much more effective due to the growing demand for minimally invasive surgical treatments and the application of medical robotics to assist with surgical procedures. As a result, these factors are promoting market growth.
High initial costs serve as a notable restraint in the medical robotics market, hindering its growth. Robotic hardware, like surgical robots or robotic-assisted surgery systems, can have unaffordable initial costs. Moreover, the integration of medical robots frequently requires specialized operating rooms and infrastructural changes, which raises the initial costs even more. However, healthcare personnel must complete specialized training in order to safely operate medical robots and carry out procedures.
By leveraging robotic systems, drug delivery becomes more precise, targeted, and efficient. Medical robots are able to precisely regulate when and how much medication is administered, ensuring that the appropriate amount reaches the intended site. This is particularly helpful for medical procedures that require extreme precision, like intravenous drug delivery or cancer therapy. Additionally, robotics can facilitate targeted drug delivery, which minimizes exposure to healthy tissues and cells by directing medication specifically to affected tissues or cells. This method increases the therapeutic effect while lowering side effects. These factors propel market demand.
Medical robots need regular repairs as well as routine maintenance. To avoid expensive interruptions, it is crucial to guarantee a steady supply of replacement parts and skilled technicians for maintenance. Medical robots are essential to many aspects of healthcare, such as diagnosis and surgery. Any unforeseen malfunction or breakdown can cause a large amount of downtime, which could delay patient care and be inconvenient for medical staff. Medical robot malfunctions have a chance to put patient safety at risk by causing mistakes, problems, or unfavourable outcomes. Therefore, maintenance and repair is a significant barrier to market demand.
The COVID-19 pandemic significantly influenced the medical robotics market. With the need to minimize human-to-human contact, the demand for medical robots surged. Telemedicine and telehealth saw rapid adoption, leading to the development of robots for remote consultations and surgeries, facilitating patient care while maintaining social distancing. Robots were also deployed for disinfection, utilizing UV-C light and other methods to sanitize healthcare environments, reducing the risk of transmission. This period accelerated research and development, spawning innovations like robots for sample collection, diagnostics, and remote monitoring. The pandemic also emphasized the role of medical robots in training healthcare professionals through simulated procedures.
The laparoscopy segment is estimated to hold the largest share. Laparoscopic devices have proven to be effective tools for diagnostic and therapeutic purposes. Increases in funding and reimbursement policies have been noted for surgeries involving laparoscopies. Robot-assisted laparoscopy procedures have become increasingly common in recent years. Additionally, due to the numerous advantages of laparoscopic surgery, including small or no incision, brief hospital stays, less pain, short recovery times, fewer wounds, and decreased blood loss, there is a growing need for robot-assisted minimally invasive surgery.
The hospitals segment is anticipated to have lucrative growth during the forecast period, due to hospitals and clinics provide patients with all types of treatment options and consultations in a single visit. The number of hospitals and surgeries performed annually is driving the growth in hospitals and clinics. The increasing use of medical robotics for a range of tasks, such as surgery, IV preparations, sterilization, logistics, diagnostics, and more, contributes to the hospitals and clinics market segment.
North America commanded the largest market share during the extrapolated period due to its sophisticated healthcare infrastructure, strong capacity for research and development, and sizable number of healthcare institutions. The region is a center for technological innovation, with many well-known medical robot producers, academic institutions, and medical facilities constantly pushing the boundaries of the industry. North America leads the world in telemedicine, robotic-assisted surgery, and rehabilitation robot innovations, which drives market demand in this region.
Europe is expected to witness profitable growth over the projection period, due to the increasing geriatric population in developed countries and the globalization of healthcare. Numerous medical robotics research facilities and innovation hubs are located in Europe. To promote the advancement of medical robotic technology development and implementation, these centers work with influential individuals in the industry as well as academic institutions. European nations continue to show a strong commitment to investing in healthcare, giving financial support to healthcare facilities in this region.
Some of the key players in the Medical Robotics Market include: Titan Medical Inc., Renishaw Plc, Medrobotics Corporation, OR Productivity plc, Hansen, Mazor Robotics, iRobot Corporation, Intuitive Surgical, Health Robotics SLR, Mako Surgical Corp., Stereotaxis Inc., Accuray, Varian Medical Systems, Smith & Nephew, Zimmer Biomet, Medtronic and Stryker.
In Sept 2022 - Titan Medical entered into a limited development program agreement with Medtronic, whereby Medtronic will assess the effectiveness of Titan's instruments and cameras in gynecological procedures aligning with Titan Medical's plan to focus on gynecological procedures as the initial application for its surgical robot.
In Nov 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants.
In June 2020, Accuracy (US) launched the Cyber Knife S7 System a next-generation CyberKnife platform with advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radio surgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.